No definition available.
Other and unspecified immunodeficiencies with predominantly antibody defects
DOID EFO Endpoint Browser PheWeb
D3_IMMUDEFANTIBODYNAS
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
523 |
4. Check minimum number of eventsNone |
523 |
5. Include endpointsNone |
523 |
6. Filter based on genotype QC (FinnGen only) |
446 |
Control definitions (FinnGen only)
- Control exclude
- D3_IMMUNEMECHANISM
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified immunodeficiencies with predominantly antibody defects
based on the number of shared cases.
Similar with more cases:
- Immunodeficiency with predominantly antibody defects
- Immunodeficiencies
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1635 | 939 | 695 |
| Only index persons | 1497 | 874 | 623 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.03 | 0.02 |
| Only index persons | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 44.50 | 48.34 | 39.35 |
| Only index persons | 44.51 | 48.28 | 39.22 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 446 | 295 | 151 |
| Unadjusted period prevalence (%) | 0.09 | 0.10 | 0.07 |
| Median age at first event (years) | 50.03 | 49.97 | 50.16 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 466
- Matched controls
- 4660
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
307.7
278
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
262.0
226
*
ZX120
NOMESCO Finland
Intravenous
17.3
207.2
222
233
WW200
NOMESCO Finland
Immunization
41.0
205.7
131
44
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
22.9
199.9
166
110
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
196.1
174
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
192.4
171
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
182.7
163
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
17.0
143.2
134
108
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
25.5
130.1
96
47
J01MA14
ATC
moxifloxacin; systemic
11.7
127.6
160
200
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
10.6
115.0
153
205
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
17.6
114.4
101
72
J01MA12
ATC
levofloxacin; systemic
8.1
110.7
218
457
J47
ICD-10 Finland
Bronchiectasis
31.2
109.9
74
28
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
104.2
96
*
TPH04
NOMESCO Finland
Cathetrisation of vein
6.8
95.4
237
613
TDM10
NOMESCO Finland
Puncture of maxillary antrum
13.4
94.5
98
91
6BA02, ,
NOMESCO Finland
289.5
94.4
93
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.4
92.5
180
365
GD1AA
NOMESCO Finland
Thorax X-ray examination
8.6
92.1
375
1513
J18.9
ICD-10 Finland
Pneumonia, unspecified
6.5
90.4
242
665
H02AB07
ATC
prednisone; oral
7.4
89.3
169
332
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
13.5
86.5
88
79
H02AB06
ATC
prednisolone; systemic
7.9
84.0
374
1588
J45.1
ICD-10 Finland
Nonallergic asthma
8.7
83.4
124
186
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
8.8
83.2
122
180
R50.9
ICD-10 Finland
Fever, unspecified
6.4
81.5
187
440
C01CA24
ATC
epinephrine; parenteral
8.3
79.8
124
195
R03BB04
ATC
tiotropium bromide; inhalant
8.5
77.8
117
177
UGC12
NOMESCO Finland
Flexible bronchoscopy
9.6
76.7
101
130
H02AB09
ATC
hydrocortisone; systemic
15.0
75.9
71
55
XW000
NOMESCO Finland
Bone marrow biopsy
13.2
75.4
77
69
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
8.9
74.4
106
150
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
74.0
69
*
J45.0
ICD-10 Finland
Predominantly allergic asthma
6.9
70.9
133
254
J46
ICD-10 Finland
Status asthmaticus
15.3
68.6
63
47
TGC00
NOMESCO Finland
Bronchial lavation
14.4
67.1
64
51
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.9
64.1
243
849
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.6
63.4
123
241
R03DA04
ATC
theophylline; systemic, rectal
10.9
63.3
73
78
Z3231
NOMESCO Finland
Registered nurse
4.8
62.8
248
891
J32.4
ICD-10 Finland
Chronic pansinusitis
21.7
61.5
47
24
R03DC03
ATC
montelukast; oral
5.1
61.1
184
532
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
8.4
61.1
89
128
J45.9
ICD-10 Finland
Asthma, unspecified
4.9
59.2
192
587
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.5
57.6
255
984
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
4.8
57.5
191
593
Z2221
NOMESCO Finland
Medical doctor
4.5
56.8
238
880
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
8.1
56.2
83
121
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.7
55.2
181
554
R03BA02
ATC
budesonide; inhalant
4.7
54.9
180
551
Z3226
NOMESCO Finland
Physiotherapist
4.6
53.9
183
574
XF400
NOMESCO Finland
ECG with 12 standard connections
5.1
53.2
143
372
H02AB04
ATC
methylprednisolone; systemic
5.1
52.4
140
362
WW500
NOMESCO Finland
Blood transfusion
9.9
52.1
64
74
R03AC12
ATC
salmeterol; inhalant
9.1
51.6
68
86
R03BB01
ATC
ipratropium bromide; inhalant
11.0
49.9
56
57
J01FA06
ATC
roxithromycin; oral
4.1
49.0
290
1333
R4110
NOMESCO Finland
Physiotherapy
4.0
48.2
229
904
R03AC13
ATC
formoterol; inhalant
7.8
47.7
72
107
J01.0
ICD-10 Finland
Acute maxillary sinusitis
4.0
47.0
225
889
ZXE10
NOMESCO Finland
More than one and less than three hours
3.9
46.9
262
1148
J45.8
ICD-10 Finland
Mixed asthma
10.4
46.3
54
58
UDH02
NOMESCO Finland
Rhinopharyngoscopy
6.0
44.6
90
180
A07AA02
ATC
nystatin; oral
7.2
44.6
72
115
L03AA02
ATC
filgrastim; parenteral
10.0
44.2
53
59
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.5
43.7
137
397
JN4BD
NOMESCO Finland
Extensive body CT
5.4
43.5
101
229
GD1AD
NOMESCO Finland
Thorax CT examination
6.8
43.4
74
125
R01AD05
ATC
budesonide; nasal
5.8
42.2
88
181
UJF30
NOMESCO Finland
Ileoscopy through colon
5.0
42.2
106
257
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
16.9
42.2
36
23
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
8.0
42.1
61
86
R03AK11
ATC
formoterol and fluticasone; inhalant
11.5
40.8
44
42
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
17.4
40.5
34
21
M05BA04
ATC
alendronic acid; oral
6.0
40.0
79
154
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
5.5
39.9
87
186
Z2446
NOMESCO Finland
Social worker
5.3
39.9
93
211
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
10.9
39.5
44
44
ZXE00
NOMESCO Finland
One hour or less
3.5
39.1
272
1329
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.5
38.6
69
122
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.3
38.1
70
127
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
38.0
200
819
L04AX01
ATC
azathioprine; systemic
7.7
37.7
56
81
R01AD08
ATC
fluticasone; nasal
3.4
37.4
222
977
Z01.8
ICD-10 Finland
Other specified special examinations
3.6
37.1
178
685
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
+∞
37.0
35
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.9
36.8
72
139
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.7
36.2
98
251
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.1
36.1
86
198
J01MA02
ATC
ciprofloxacin; systemic
3.3
35.9
241
1136
ZX112
NOMESCO Finland
Subcutaneous
10.2
35.9
42
45
R03AK08
ATC
formoterol and beclometasone; inhalant
6.7
35.5
60
100
J05AB11
ATC
valaciclovir; oral
3.8
35.4
140
473
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.0
35.2
127
402
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
10.1
35.0
41
44
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
+∞
34.8
33
*
ZXD10
NOMESCO Finland
Scheduled procedure
3.3
34.8
249
1213
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.7
34.7
345
2042
D70.82
ICD-10 Finland
Drug-induced neutropenia
11.1
34.7
38
37
R03AC02
ATC
salbutamol; inhalant
3.7
34.4
353
2125
J01FA15
ATC
telithromycin; oral
4.5
34.2
97
257
R01AD09
ATC
mometasone; nasal
3.3
33.7
306
1702
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
44.8
33.7
41
10
R03DC01
ATC
zafirlukast; oral
11.7
33.3
35
32
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.8
33.2
130
434
J01FF01
ATC
clindamycin; systemic
3.3
32.8
189
804
A03FA01
ATC
metoclopramide; systemic, rectal
3.3
32.3
171
691
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.4
31.8
155
595
R03AK07
ATC
formoterol and budesonide; inhalant
3.3
31.7
164
652
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
6.1
31.7
59
108
TAB00
NOMESCO Finland
Lumbar puncture
5.8
31.1
62
121
ZX108
NOMESCO Finland
Inhalation
50.1
31.1
37
8
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
3.1
31.1
202
917
J02AC01
ATC
fluconazole; systemic
3.1
31.0
268
1426
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
6.2
30.8
56
100
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
4.7
30.1
77
187
ZXA10
NOMESCO Finland
Bilateral
3.4
30.0
142
533
XQ800
NOMESCO Finland
Prick test
4.5
29.7
81
207
J01FA10
ATC
azithromycin; systemic
3.5
29.2
364
2350
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
47.2
29.1
35
8
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.2
28.9
40
53
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.2
28.8
88
245
J31.0
ICD-10 Finland
Chronic rhinitis
4.1
28.7
91
260
ZX114
NOMESCO Finland
Intramuscular
9.6
28.0
34
38
R03BA05
ATC
fluticasone; inhalant
3.2
27.9
150
604
R05
ICD-10 Finland
Cough
3.1
27.9
161
676
J01FA09
ATC
clarithromycin; systemic
2.9
27.8
217
1075
J45
ICD-10 Finland
Asthma
4.0
27.5
92
273
D80.2
ICD-10 Finland
Selective deficiency of immunoglobulin A [IgA]
+∞
27.4
26
*
A04AA01
ATC
ondansetron; systemic, rectal
4.5
27.3
75
192
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
3.1
27.1
335
2108
C03CA01
ATC
furosemide; systemic
3.1
26.7
152
631
A41.9
ICD-10 Finland
Sepsis, unspecified
7.2
26.4
41
62
D84.18
ICD-10 Finland
Other specified defect in the complement system
+∞
26.3
25
*
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
26.3
25
*
L04AA06
ATC
mycophenolic acid; systemic
9.5
26.2
32
36
N02AA05
ATC
oxycodone; systemic
3.4
25.8
116
418
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
5.6
25.4
51
100
JN4AD
NOMESCO Finland
Body CT examination
3.9
25.4
87
262
R03AK03
ATC
[U] fenoterol and ipratropium bromide
6.7
25.3
42
68
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.5
25.3
68
171
XA800
NOMESCO Finland
Neuropsychological investigation
4.9
25.1
60
137
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
6.2
25.1
45
79
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.6
25.0
42
69
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
21.6
24.7
36
18
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
9.6
24.1
29
32
N03AX16
ATC
[U] pregabalin
2.9
24.0
155
684
WZC30
NOMESCO Finland
Teaching
3.2
24.0
121
465
JN6AD
NOMESCO Finland
CT of torso and neck
9.9
23.7
28
30
N02AX02
ATC
tramadol; systemic, rectal
2.7
23.7
246
1380
R06AE07
ATC
cetirizine; oral
2.7
23.7
273
1612
R03BA01
ATC
beclometasone; inhalant
3.4
23.5
103
363
A01AB09
ATC
miconazole; local oral
4.1
23.3
70
191
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.3
23.1
104
373
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
23.1
233
1285
M04AA01
ATC
allopurinol; systemic
3.9
23.0
75
217
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.3
23.0
66
174
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
8.6
22.9
30
37
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.9
22.8
54
122
J01DA06
ATC
[U] cefuroxime
3.1
22.6
113
431
XG410
NOMESCO Finland
Flow-volume spirometry
6.4
22.5
39
66
1XC02, ,
NOMESCO Finland
37.1
22.3
28
8
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
9.5
22.3
27
30
J05AB01
ATC
aciclovir; systemic
2.8
22.2
155
709
R03BA08
ATC
ciclesonide; inhalant
3.7
22.1
79
244
H04.10
ICD-10 Finland
Dry eye syndrome
3.3
22.0
99
354
R06.0
ICD-10 Finland
Dyspnoea
2.7
22.0
167
797
R81
ICPC
Pneumonia
5.9
21.9
41
75
A02BC02
ATC
pantoprazole; systemic
2.9
21.8
356
2453
D64.9
ICD-10 Finland
Anaemia, unspecified
3.9
21.7
71
206
J01AA02
ATC
doxycycline; systemic
3.6
21.6
402
2971
Z3229
NOMESCO Finland
Other healthcare associate professional
3.9
21.4
70
203
ZXE20
NOMESCO Finland
More than three and less than five hours
3.2
21.3
97
349
UJF32
NOMESCO Finland
Coloscopy
2.7
21.2
152
702
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
19.0
21.2
32
18
J20
ICD-10 Finland
Acute bronchitis
3.4
21.0
89
306
D80.6
ICD-10 Finland
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
+∞
21.0
20
*
2790C
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[DEFICIENTIA IMMUNOGLOBULINI ALIA]
+∞
21.0
20
*
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
31.7
20.8
27
9
D84.9
ICD-10 Finland
Immunodeficiency, unspecified
219.4
20.7
21
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
6.3
20.7
36
61
R4120
NOMESCO Finland
Occupational therapy
4.0
20.7
65
183
R01BA52
ATC
pseudoephedrine, combinations; oral
2.6
20.6
189
983
R01AD58
ATC
fluticasone, combinations; nasal
2.6
20.5
173
865
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
6.8
20.4
33
52
ZY010
NOMESCO Finland
Hospital outpatient
4.2
20.3
58
152
WZC00
NOMESCO Finland
Treatment plan or consultation
2.5
20.3
224
1268
R03AC03
ATC
terbutaline; inhalant
3.1
20.0
99
373
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.3
19.9
84
288
RD210, ,
NOMESCO Finland
6.4
19.8
34
57
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
8.1
19.7
27
35
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.4
19.6
235
1375
S01GX01
ATC
cromoglicic acid; ophthalmic
2.6
19.5
149
707
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
17.7
19.4
30
18
ZXA05
NOMESCO Finland
Left side
2.7
19.4
142
659
WX002
NOMESCO Finland
Sedation and analgesia
2.8
19.3
119
506
XF600
NOMESCO Finland
Bloodpressure measurement
4.1
19.2
56
149
Z2445
NOMESCO Finland
Psychologist
4.3
19.2
52
131
ZXD05
NOMESCO Finland
Urgent procedure
2.5
19.2
181
948
A28
ICPC
Limited function/disability NOS
3.0
19.1
98
376
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.0
19.1
43
93
J01DB01
ATC
cefalexin; oral
4.1
18.7
426
3356
ZXD20
NOMESCO Finland
Day surgery
3.1
18.6
92
346
A02BC01
ATC
omeprazole; systemic
2.5
18.4
157
781
N03AX12
ATC
[U] gabapentin; oral
2.8
18.1
114
488
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.7
17.9
43
98
Z50.1
ICD-10 Finland
Other physical therapy
4.6
17.8
44
103
A01AB04
ATC
amphotericin B; local oral
4.8
17.7
42
95
WX892
NOMESCO Finland
Monitored bed care
3.8
17.7
58
168
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
17.6
87
326
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
17.8
17.6
27
16
M35.7
ICD-10 Finland
Hypermobility syndrome
8.1
17.6
24
31
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.9
17.6
101
412
RS221, ,
NOMESCO Finland
7.4
17.6
26
37
R1250
NOMESCO Finland
Evaluation of functional capability
6.0
17.5
32
57
N05CF01
ATC
zopiclone; oral
2.4
17.5
179
964
ZXA00
NOMESCO Finland
Right side
2.5
17.4
149
741
N05CD07
ATC
temazepam; oral
3.4
17.3
68
222
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
5.9
17.2
32
58
N03AE01
ATC
clonazepam; systemic
4.2
17.2
49
128
R06AE09
ATC
levocetirizine; oral
2.8
17.1
102
424
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.1
16.9
37
78
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.0
16.8
83
311
M36.8*D80.1
ICD-10 Finland
Systemic disorders of connective tissue in hypogammaglobulinaemia
+∞
16.8
16
*
J01DA01
ATC
[U] cefalexin
2.4
16.7
319
2224
ZYC01
NOMESCO Finland
Remote contact by phone
3.7
16.6
56
165
L01BA01
ATC
methotrexate; systemic
5.5
16.5
33
64
Z71.8
ICD-10 Finland
Other specified counselling
2.3
16.5
211
1244
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
16.5
139
684
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.3
16.4
68
229
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
5.2
16.4
35
72
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.2
16.3
73
258
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.2
16.1
72
254
R4190
NOMESCO Finland
Nutritional therapy
4.1
16.1
47
125
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.1
16.1
73
260
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.9
15.9
36
78
N06AX21
ATC
duloxetine; oral
2.8
15.9
92
375
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
15.9
94
388
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
7.5
15.8
23
32
UJF92
NOMESCO Finland
Capsular endoscopy
6.3
15.8
27
45
R01AD12
ATC
fluticasone furoate; nasal
2.2
15.7
197
1145
J01DA08
ATC
[U] cefaclor
3.0
15.7
81
310
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.3
15.5
32
64
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.9
15.3
80
308
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
5.4
15.3
31
61
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
5.9
15.3
28
50
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
5.2
15.2
32
65
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
46.6
15.2
18
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.7
15.1
29
54
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.4
15.1
57
181
A02BC05
ATC
esomeprazole; systemic
2.2
15.0
223
1381
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.2
15.0
180
1025
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
17.2
14.9
23
14
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.9
14.9
76
289
N05BA01
ATC
diazepam; systemic, rectal
2.8
14.7
87
358
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.9
14.7
78
303
D86.0
ICD-10 Finland
Sarcoidosis of lung
+∞
14.7
14
*
A02BA02
ATC
ranitidine; systemic
2.6
14.6
105
476
L04AX03
ATC
methotrexate; systemic
3.0
14.6
70
257
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.3
14.6
60
201
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.7
14.6
49
144
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
3.9
14.5
44
120
D70.89
ICD-10 Finland
Neutropenic splenomegaly
14.0
14.4
24
18
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
14.0
14.4
24
18
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.9
14.3
74
283
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.3
14.3
57
187
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
5.4
14.3
29
57
B01AB04
ATC
dalteparin; parenteral
4.3
14.3
38
94
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.9
14.2
77
302
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.5
14.2
52
162
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.5
14.1
35
82
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
14.0
123
610
E0000UV, ,
ATC
2.1
14.0
234
1504
B34.9
ICD-10 Finland
Viral infection, unspecified
4.8
14.0
32
70
R06AX27
ATC
desloratadine; oral
2.2
13.9
183
1073
ZX121
NOMESCO Finland
Central venous catheter
20.8
13.9
20
10
R01AD11
ATC
triamcinolone; nasal
3.1
13.9
65
235
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
13.8
101
461
C10AC01
ATC
colestyramine; oral
5.4
13.8
28
55
R11
ICD-10 Finland
Nausea and vomiting
3.0
13.8
66
242
AA1AD
NOMESCO Finland
CT of head and brain
2.2
13.6
148
803
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
+∞
13.6
13
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
144.0
13.5
14
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.8
13.5
76
304
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.0
13.3
39
104
XCK00
NOMESCO Finland
Perimetry
3.9
13.2
40
109
XF404
NOMESCO Finland
Ambulatory ECG
3.3
13.2
53
175
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.7
13.1
43
124
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
4.3
13.1
35
87
B29
ICPC
Lymph/immune mech sympt/complt other
29.3
13.0
17
6
R06AX22
ATC
ebastine; oral
2.4
13.0
112
550
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
2.3
12.9
124
637
H02AB02
ATC
dexamethasone; systemic
2.7
12.9
75
305
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
6.0
12.9
23
40
J01FA01
ATC
erythromycin; systemic
2.6
12.8
85
369
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.3
12.8
127
661
XG474
NOMESCO Finland
Exhalation nntrogen oxide
4.7
12.8
30
67
WX402
NOMESCO Finland
General anaesthesia
2.2
12.8
137
737
A04AA02
ATC
granisetron; systemic, transdermal
3.4
12.7
48
152
C08DA01
ATC
verapamil; systemic
4.4
12.7
33
80
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
4.4
12.7
33
80
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
4.4
12.7
32
76
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
33.0
12.6
16
5
J96.0
ICD-10 Finland
Acute respiratory failure
17.9
12.6
19
11
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.4
12.6
106
514
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
4.2
12.6
34
85
L28
ICPC
Limited function/disability (L)
2.4
12.6
98
459
D84.19
ICD-10 Finland
Unspecified defect in the complement system
+∞
12.6
12
*
3AC01, ,
NOMESCO Finland
20.7
12.5
18
9
C82.1
ICD-10 Finland
Follicular lymphoma grade II
25.1
12.5
17
7
R13
ICD-10 Finland
Dysphagia
3.2
12.5
51
170
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.3
12.3
25
49
N06AA09
ATC
amitriptyline; systemic
2.9
12.3
62
233
M81.9
ICD-10 Finland
Osteoporosis, unspecified
4.1
12.3
35
91
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.2
12.2
51
172
127
Kela drug reimbursment
Transplant complication
9.0
12.2
25
29
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
9.0
12.2
25
29
R03BC03
ATC
nedocromil; inhalant
3.2
12.2
52
178
M05BX04
ATC
denosumab; parenteral
3.7
12.1
40
116
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
22.0
12.1
17
8
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.0
12.0
26
54
R51.81
ICD-10 Finland
Facial pain NOS
4.9
12.0
27
58
R53
ICD-10 Finland
Malaise and fatigue
2.1
12.0
143
800
A02BC03
ATC
lansoprazole; oral
2.1
12.0
148
839
A46
ICD-10 Finland
Erysipelas
2.6
11.9
77
330
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
6.1
11.9
21
36
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
15.2
11.9
19
13
P01AB01
ATC
metronidazole; oral, rectal
2.0
11.9
216
1408
J01
ICD-10 Finland
Acute sinusitis
3.3
11.8
48
159
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.7
11.8
28
63
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.5
11.8
43
133
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
19.5
11.7
17
9
R01AD01
ATC
beclometasone; nasal
2.4
11.6
96
461
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
+∞
11.5
11
*
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.7
11.4
66
267
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.9
11.4
59
225
R06AX13
ATC
loratadine; oral
2.4
11.4
93
444
L04AA01
ATC
[U] ciclosporin
10.9
11.4
21
20
P01BA02
ATC
hydroxychloroquine; oral
2.9
11.4
56
208
B99
ICPC
Blood/lymph/spleen disease other
36.0
11.3
14
*
WVA20
NOMESCO Finland
Medicine administration
4.8
11.3
26
57
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
17.6
11.3
17
10
A06AD11
ATC
lactulose; oral
2.6
11.3
71
300
B28
ICPC
Limited function/disability (B)
25.7
11.2
15
6
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.4
11.1
86
400
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.1
11.0
139
790
S01AA01
ATC
chloramphenicol; ophthalmic
3.8
11.0
34
94
J33.8
ICD-10 Finland
Other polyp of sinus
5.6
11.0
21
39
L04AA13
ATC
[U] leflunomide
5.6
11.0
21
39
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
44.4
11.0
13
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.8
10.9
59
230
N03AX11
ATC
topiramate; oral
4.5
10.9
27
63
N02BF02
ATC
pregabalin; oral
3.0
10.9
49
173
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.6
10.9
70
299
N06AA10
ATC
nortriptyline; systemic
4.7
10.8
25
55
UJD02
NOMESCO Finland
Gastroscopy
3.6
10.8
36
105
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
18.4
10.8
16
9
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
18.4
10.8
16
9
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
5.8
10.8
20
36
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.5
10.8
78
352
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
22.1
10.7
15
7
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
13.3
10.7
18
14
M05BA07
ATC
risedronic acid; oral
5.5
10.7
21
40
A06AC01
ATC
ispaghula (psylla seeds); oral
2.1
10.7
137
783
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
5.2
10.6
22
44
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
5.6
10.5
20
37
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
5.6
10.5
20
37
GD1DG
NOMESCO Finland
Extremely extensive MRI examination of pleura with high field magnet
112.5
10.5
11
*
D84.8
ICD-10 Finland
Other specified immunodeficiencies
+∞
10.5
10
*
D84.1
ICD-10 Finland
Defects in the complement system
+∞
10.5
10
*
TKC20
NOMESCO Finland
Catheterisation of bladder
3.4
10.4
39
123
J32.8
ICD-10 Finland
Other chronic sinusitis
19.3
10.3
15
8
C03DA01
ATC
spironolactone; oral
2.6
10.3
62
256
L03AA13
ATC
pegfilgrastim; parenteral
3.4
10.2
37
114
R96
ICPC
Asthma
2.6
10.2
64
270
H92.0
ICD-10 Finland
Otalgia
3.0
10.2
48
174
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
9.4
10.1
20
22
R05CB01
ATC
acetylcysteine; inhalant, oral
15.0
10.1
16
11
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
15.0
10.1
16
11
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.6
10.0
60
247
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.5
10.0
66
285
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
17.2
9.9
15
9
J01.4
ICD-10 Finland
Acute pansinusitis
12.6
9.9
17
14
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.3
9.9
20
39
R07.4
ICD-10 Finland
Chest pain, unspecified
2.0
9.9
145
866
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.6
9.8
60
249
SPAT1262
SPAT
Handing over of treatment supplies
2.3
9.8
87
429
R51.80
ICD-10 Finland
Headache
2.1
9.8
105
559
WX882
NOMESCO Finland
High dependency care
3.9
9.8
29
78
DHB50
NOMESCO Finland
Turbinoplasty
4.5
9.7
24
56
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
56.2
9.7
11
*
ZX110
NOMESCO Finland
Intracutaneous
56.2
9.7
11
*
B03XA02
ATC
darbepoetin alfa; parenteral
8.7
9.7
20
24
TK800
NOMESCO Finland
Hemodialysis
8.7
9.7
20
24
T78.4
ICD-10 Finland
Allergy, unspecified
3.5
9.6
34
103
H65.3
ICD-10 Finland
Chronic mucoid otitis media
4.2
9.6
26
65
XG466
NOMESCO Finland
Sleep oxymetry
5.0
9.6
21
44
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.7
9.6
53
209
A07EA06
ATC
budesonide; oral, local oral
3.7
9.5
31
89
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.5
9.5
33
99
C07AB07
ATC
bisoprolol; oral
1.9
9.5
208
1413
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
102.0
9.4
10
*
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
30.7
9.4
12
*
J01DC02
ATC
cefuroxime; systemic
3.3
9.4
37
120
A03
ICPC
Fever
2.1
9.4
109
596
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
+∞
9.4
9
*
D83.1
ICD-10 Finland
Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
+∞
9.4
9
*
D83.8
ICD-10 Finland
Other common variable immunodeficiencies
+∞
9.4
9
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
9.4
9
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
22.2
9.4
13
6
M13.9
ICD-10 Finland
Arthritis, unspecified
2.9
9.4
47
176
TPH07
NOMESCO Finland
Cathetrisation of artery
2.5
9.3
61
262
Z31.5
ICD-10 Finland
Genetic counselling
2.9
9.3
46
171
R49.01
ICD-10 Finland
Functional dysphonia
3.9
9.2
27
72
Z50.5
ICD-10 Finland
Speech therapy
5.2
9.2
19
38
SPAT1255
SPAT
Intravenous administration of medicine
3.3
9.2
36
117
L03AA14
ATC
lipegfilgrastim; parenteral
4.9
9.1
20
42
R02
ICPC
Shortness of breath/dyspnoea
2.3
9.1
75
357
E000002, ,
ATC
2.4
9.1
71
330
A41.8
ICD-10 Finland
Other specified sepsis
7.3
9.1
21
30
A12AA04
ATC
calcium carbonate; oral
9.3
9.1
18
20
R42
ICD-10 Finland
Dizziness and giddiness
2.0
9.1
113
634
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.6
9.1
30
87
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
37.5
9.1
11
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.2
9.0
36
118
X58
ICD-10 Finland
Exposure to other specified factors
2.1
9.0
92
479
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.6
9.0
57
241
N02AC04
ATC
dextropropoxyphene; oral
4.5
9.0
22
51
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
24.6
8.9
12
5
J01EA01
ATC
trimethoprim; systemic
2.0
8.9
131
778
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
7.0
8.9
21
31
R52.0
ICD-10 Finland
Acute pain
3.6
8.9
30
88
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
8.9
8.9
18
21
J02AC02
ATC
itraconazole; systemic
2.1
8.8
97
520
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
6.8
8.8
21
32
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
3.2
8.7
35
115
N17.8
ICD-10 Finland
Other acute renal failure
14.4
8.7
14
10
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
7.9
8.7
19
25
G44.2
ICD-10 Finland
Tension-type headache
2.2
8.7
84
427
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
3.0
8.7
39
137
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
8.7
42
154
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.8
8.7
44
166
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
8.5
8.7
18
22
A03FA02
ATC
cisapride; oral, rectal
2.9
8.6
41
149
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
7.2
8.6
20
29
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.4
8.6
65
298
A07AA09
ATC
vancomycin; oral
10.3
8.6
16
16
EBA15
NOMESCO Finland
Extraction of multiple teeth
3.7
8.5
27
76
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.6
8.5
19
26
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
4.0
8.5
24
62
N07BC02
ATC
methadone; systemic
28.1
8.5
11
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
28.1
8.5
11
*
J15.8
ICD-10 Finland
Other bacterial pneumonia
20.5
8.5
12
6
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
20.5
8.5
12
6
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.9
8.5
147
920
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.0
8.5
39
139
B03BA03
ATC
hydroxocobalamin; parenteral
3.5
8.5
29
86
J01CA04
ATC
amoxicillin; systemic
2.2
8.5
402
3433
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.1
8.4
36
123
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
5.0
8.4
18
37
J01.1
ICD-10 Finland
Acute frontal sinusitis
4.8
8.4
19
41
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
13.1
8.4
14
11
D02AX
ATC
Other emollients and protectives
3.7
8.4
27
77
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
+∞
8.4
8
*
J06BA02
ATC
immunoglobulins, normal human, for intravascular adm.; systemic
+∞
8.4
8
*
D81.0
ICD-10 Finland
Severe combined immunodeficiency [SCID] with reticular dysgenesis
+∞
8.4
8
*
WX730
NOMESCO Finland
Conventional respirator
11.0
8.3
15
14
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
14.8
8.2
13
9
R01BA51
ATC
phenylpropanolamine, combinations; oral
2.3
8.2
67
318
B01AB05
ATC
enoxaparin; parenteral
1.9
8.2
146
921
A11CC03
ATC
alfacalcidol; systemic
4.9
8.2
18
38
M03BX01
ATC
baclofen; systemic
4.9
8.2
18
38
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
12.0
8.1
14
12
H66.9
ICD-10 Finland
Otitis media, unspecified
2.5
8.1
55
240
DMB10
NOMESCO Finland
Radical maxillary antrotomy
17.6
8.1
12
7
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
34.0
8.1
10
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
9.2
8.1
16
18
D50.8
ICD-10 Finland
Other iron deficiency anaemias
9.2
8.1
16
18
J01DA09
ATC
[U] cefadroxil
1.9
8.1
132
809
N06AX17
ATC
milnacipran; oral
10.3
8.1
15
15
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
10.3
8.1
15
15
J33.0
ICD-10 Finland
Polyp of nasal cavity
4.3
8.1
21
51
K11.2
ICD-10 Finland
Sialoadenitis
4.0
8.1
23
60
F81.0
ICD-10 Finland
Specific reading disorder
22.5
8.0
11
5
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.9
8.0
38
138
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
2.3
8.0
67
321
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
4.1
8.0
22
56
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
8.0
211
1495
M05BB03
ATC
alendronic acid and colecalciferol; oral
6.3
7.9
20
33
RK110, ,
NOMESCO Finland
13.3
7.9
13
10
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.9
7.9
23
61
R2110
NOMESCO Finland
Giving the first information
2.8
7.9
39
145
R49.08
ICD-10 Finland
Other specified dysphonia
4.2
7.9
21
52
M48.0
ICD-10 Finland
Spinal stenosis
2.3
7.9
60
276
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.8
7.9
40
151
M01AH01
ATC
celecoxib; oral
2.0
7.9
90
488
Z49.1
ICD-10 Finland
Extracorporeal dialysis
11.1
7.8
14
13
M01CB01
ATC
sodium aurothiomalate; parenteral
11.1
7.8
14
13
DPA30
NOMESCO Finland
Sphenotomy
9.6
7.8
15
16
4224
FHL
Endonasal anthrostomy
9.6
7.8
15
16
J37.0
ICD-10 Finland
Chronic laryngitis
3.7
7.8
25
71
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
3.4
7.8
28
86
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.6
7.8
26
76
R20.2
ICD-10 Finland
Paraesthesia of skin
2.6
7.8
47
194
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
3.5
7.8
27
81
A07EC01
ATC
sulfasalazine; oral, rectal
2.6
7.8
45
182
318
Kela drug reimbursment
Teriparatide
15.3
7.7
12
8
4222
FHL
Endonasal etmoidectomy
15.3
7.7
12
8
L04AD02
ATC
tacrolimus; systemic
7.6
7.7
17
23
DPA20
NOMESCO Finland
Trephine of frontal sinus
45.8
7.7
9
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.2
7.7
31
102
XKD00
NOMESCO Finland
Uroflowmetry
2.4
7.7
58
265
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.1
7.7
82
432
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
3.7
7.7
24
67
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
3.7
7.7
24
67
R05
ICPC
Cough
1.8
7.7
142
904
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
8.2
7.7
16
20
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
18.7
7.6
11
6
UKC02
NOMESCO Finland
Cystoscopy
2.3
7.6
64
307
5BA08, ,
NOMESCO Finland
12.1
7.6
13
11
H26.3
ICD-10 Finland
Drug-induced cataract
12.1
7.6
13
11
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
4.2
7.6
20
49
XCK10
NOMESCO Finland
Photography of fundus of eye
2.5
7.6
50
215
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
25.5
7.6
10
*
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
10.3
7.6
14
14
N30.9
ICD-10 Finland
Cystitis, unspecified
2.7
7.6
42
166
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.7
7.6
42
166
M79.6
ICD-10 Finland
Pain in limb
1.7
7.6
223
1621
K29.3
ICD-10 Finland
Chronic superficial gastritis
3.8
7.6
23
63
E87.6
ICD-10 Finland
Hypokalaemia
3.7
7.5
24
68
K07.60
ICD-10 Finland
Snapping jaw
2.8
7.5
39
149
SPAT1229
SPAT
Assessment of need for aid
2.9
7.5
35
126
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.5
7.5
26
78
L04AD01
ATC
ciclosporin; systemic
4.5
7.5
18
41
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
4.5
7.5
18
41
A07EC02
ATC
mesalazine; oral, rectal
2.9
7.5
36
132
ZX100
NOMESCO Finland
Oral
7.8
7.4
16
21
C83.00
ICD-10 Finland
Lymphocytic lymphoma
81.3
7.4
8
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
81.3
7.4
8
*
J02AC04
ATC
posaconazole; systemic
81.3
7.4
8
*
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
13.6
7.4
12
9
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.4
7.4
51
224
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.2
7.4
29
94
N06AX11
ATC
mirtazapine; oral
1.8
7.4
170
1151
A10AB05
ATC
insulin aspart; parenteral
2.5
7.4
46
193
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.3
7.3
19
46
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.3
7.3
19
46
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.3
7.3
19
46
WX203
NOMESCO Finland
Infraclavicular plexus blockade
4.3
7.3
19
46
M01AH02
ATC
rofecoxib; oral
2.2
7.3
63
305
N03AX09
ATC
lamotrigine; oral
2.8
7.3
38
145
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
9.6
7.3
14
15
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
9.6
7.3
14
15
Z94.0
ICD-10 Finland
Kidney transplant status
9.6
7.3
14
15
SXC03
NOMESCO Finland
Other oral or dental procedure
9.6
7.3
14
15
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
2.4
7.3
50
219
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.7
7.3
40
157
W19
ICD-10 Finland
Unspecified fall
2.3
7.3
57
265
H65.2
ICD-10 Finland
Chronic serous otitis media
6.0
7.3
19
33
WX722
NOMESCO Finland
PEEP
3.2
7.3
29
95
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.3
7.3
58
272
GD1AA, ,
SPAT
2.0
7.3
92
516
C09CA06
ATC
candesartan; oral
1.9
7.3
119
727
E000001, ,
ATC
1.9
7.3
101
585
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
4.4
7.3
18
42
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.8
7.3
36
134
A01
ICPC
Pain general/multiple sites
2.2
7.2
62
300
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.4
7.2
26
80
XX3DW
NOMESCO Finland
Time consuming IT work
2.3
7.2
59
280
TK810
NOMESCO Finland
Hemofiltration
20.4
7.2
10
5
A02BA03
ATC
famotidine; systemic
3.9
7.2
21
56
B81
ICPC
Anaemia vit B12/folate deficiency
3.9
7.2
21
56
RS222, ,
NOMESCO Finland
8.1
7.2
15
19
R01BA01
ATC
phenylpropanolamine; oral
2.9
7.1
34
124
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
7.1
61
295
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
12.3
7.1
12
10
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
12.3
7.1
12
10
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
9.0
7.1
14
16
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
10.2
7.1
13
13
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.3
7.1
18
43
R06AX26
ATC
fexofenadine; oral
2.5
7.1
46
197
R01AC01
ATC
cromoglicic acid; nasal
3.1
7.1
29
97
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
7.0
157
1051
R74
ICPC
Upper respiratory infection acute
1.7
7.0
192
1359
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.9
7.0
34
125
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
4.5
7.0
17
39
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
3.2
7.0
27
87
N02CC03
ATC
zolmitriptan; nasal, oral
2.7
7.0
39
155
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.9
7.0
33
120
N30.0
ICD-10 Finland
Acute cystitis
2.0
6.9
87
486
XG405
NOMESCO Finland
Education on PEF monitoring
7.7
6.9
15
20
H05AA02
ATC
teriparatide; parenteral
14.0
6.9
11
8
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
14.0
6.9
11
8
J05AH02
ATC
oseltamivir; oral
14.0
6.9
11
8
B02.9
ICD-10 Finland
Zoster without complication
2.6
6.9
40
162
ZXD35
NOMESCO Finland
Usual procedure
3.9
6.9
20
53
R5140
NOMESCO Finland
Monitoring the use of the aid
2.2
6.8
61
300
D07AC01
ATC
betamethasone; topical
1.7
6.8
172
1189
K50.8
ICD-10 Finland
Other Crohn disease
5.8
6.8
18
32
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
9.5
6.8
13
14
602
Kela drug reimbursment
Children's severe malnutrition
9.5
6.8
13
14
RS224, ,
NOMESCO Finland
9.5
6.8
13
14
GBB00
NOMESCO Finland
Tracheostomy
9.5
6.8
13
14
WX204
NOMESCO Finland
Axillary plexus blockaced
3.3
6.8
26
83
OAB50, ,
SPAT
2.5
6.8
45
194
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
3.3
6.8
25
78
D07AD01
ATC
clobetasol; topical
2.0
6.8
83
460
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
40.7
6.8
8
*
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
40.7
6.8
8
*
J01GB01
ATC
tobramycin; inhalant, parenteral
40.7
6.8
8
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
7.3
6.8
15
21
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.0
6.7
77
416
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.5
6.7
42
176
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.8
6.7
20
54
K59.09
ICD-10 Finland
Constipation, unspecified
2.7
6.7
37
146
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
22.9
6.7
9
*
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
22.9
6.7
9
*
ELA30
NOMESCO Finland
Biopsy of salivary gland
22.9
6.7
9
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.4
6.7
48
215
UDM02
NOMESCO Finland
Sinoscopy
4.1
6.7
18
45
R83
ICPC
Respiratory infection other
1.7
6.7
148
987
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
6.0
6.7
17
29
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.1
6.7
28
95
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.8
6.6
123
779
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
12.5
6.6
11
9
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
12.5
6.6
11
9
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
8.9
6.6
13
15
A10AC01
ATC
insulin (human); parenteral
2.5
6.6
41
172
B03XA01
ATC
erythropoietin; parenteral
10.2
6.6
12
12
F43.29
ICD-10 Finland
Adaptation disorder UNS
3.8
6.5
20
55
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.5
6.5
42
179
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.6
6.5
21
60
G50.1
ICD-10 Finland
Atypical facial pain
5.8
6.5
17
30
A99
ICPC
Disease/condition unspecnature/site
2.2
6.5
60
299
WX872
NOMESCO Finland
Intensive care
3.1
6.5
27
91
B01AB10
ATC
tinzaparin; parenteral
2.2
6.5
57
279
4AA24, ,
NOMESCO Finland
70.8
6.4
7
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
6.4
108
663
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
3.8
6.4
19
51
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.7
6.4
141
936
U07
ICPC
Urine symptom/complaint other
2.3
6.4
48
219
K12.10
ICD-10 Finland
Stomatitis NOS
14.6
6.4
10
7
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
14.6
6.4
10
7
JAH00
NOMESCO Finland
Laparotomy
3.7
6.4
20
56
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
2.9
6.4
29
103
M79.7
ICD-10 Finland
Fibromyalgia
3.1
6.4
27
92
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
6.1
6.4
16
27
N02BE01
ATC
paracetamol; systemic, rectal
2.1
6.4
411
3639
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
11.2
6.3
11
10
WGA11
NOMESCO Finland
Planning of pain management
11.2
6.3
11
10
RK320, ,
NOMESCO Finland
11.2
6.3
11
10
EB1WA, ,
NOMESCO Finland
11.2
6.3
11
10
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
9.4
6.3
12
13
RS121, ,
NOMESCO Finland
9.4
6.3
12
13
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.9
6.3
18
47
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
6.3
95
564
R60.0
ICD-10 Finland
Localized oedema
2.1
6.3
61
310
D80.5
ICD-10 Finland
Immunodeficiency with increased immunoglobulin M [IgM]
+∞
6.3
6
*
4732A
ICD-9 Finland
Chronic sinusitis, Ethmoidal
+∞
6.3
6
*
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
+∞
6.3
6
*
2AA01, ,
NOMESCO Finland
+∞
6.3
6
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
6.3
6
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
6.3
206
1519
5AB14, ,
NOMESCO Finland
27.1
6.2
8
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
27.1
6.2
8
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
27.1
6.2
8
*
RS220, ,
NOMESCO Finland
5.2
6.2
18
36
H25.1
ICD-10 Finland
Senile nuclear cataract
1.8
6.2
99
597
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
3.6
6.2
20
57
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.5
6.2
38
158
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
6.4
6.2
15
24
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.1
6.2
63
326
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.9
6.1
18
48
SPAT1324
SPAT
Screening procedure
0.3
6.1
22
589
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.6
6.1
36
147
J05AB09
ATC
famciclovir; oral
12.7
6.1
10
8
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
12.7
6.1
10
8
D06AX01
ATC
fusidic acid; topical
2.2
6.1
52
251
RS230, ,
NOMESCO Finland
8.8
6.1
12
14
UDC00
NOMESCO Finland
Ear microscopy
2.3
6.1
44
198
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
3.6
6.1
20
58
R4130
NOMESCO Finland
Speech therapy
3.4
6.1
21
63
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.3
6.1
17
33
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
10.2
6.1
11
11
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
10.2
6.1
11
11
N02CC05
ATC
almotriptan; oral
3.0
6.0
27
95
SHA04
NOMESCO Finland
Stomatognathic treatment, very demanding
6.2
6.0
15
25
D07AB08
ATC
desonide; topical
2.1
6.0
61
315
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
206
35
104.70
307.65
3.2
1.4
1363.17
1524.70
e6/l
0.38
172
27
197
21
161.78
307.65
3.2
1.5
—
—
—
0
0
333
302
36.13
307.65
6.1
1.6
0.84
1.43
g/l
3.64
313
282
160
44
54.85
268.15
2.2
1.3
4.43
6.41
g/l
5.06
137
35
160
44
54.85
268.15
2.2
1.3
1.72
2.86
g/l
3.56
135
34
160
44
54.85
268.15
2.2
1.3
0.24
0.34
g/l
1.36
136
35
148
29
74.32
267.15
2.9
1.3
586.18
712.35
e6/l
0.39
111
20
146
30
70.41
260.90
3.0
1.4
218.79
202.30
e6/l
0.19
113
23
166
78
32.50
233.85
2.2
1.7
0.27
0.82
g/l
3.42
138
69
117
24
64.76
207.57
1.5
3.3
2.06
1.65
umol/l
1.70
111
19
222
328
12.02
158.93
2.1
1.2
53.00
280.76
u/ml
2.00
169
305
82
13
76.33
151.13
1.2
1.1
97.80
91.77
%
0.24
82
13
353
1055
10.67
131.16
6.2
1.5
1.20
2.27
g/l
26.27
288
657
117
93
16.46
125.27
7.1
8.1
559.75
172.08
iu/ml
0.90
24
12
135
156
11.78
113.20
1.9
1.7
0.23
0.23
g/l
0.11
123
151
137
162
11.56
112.97
1.9
1.6
1.16
1.20
g/l
0.71
128
155
100
77
16.26
108.41
5.5
4.6
8405.75
3741.00
u/ml
—
8
7
213
452
7.84
106.40
3.0
1.8
—
—
—
0
0
197
430
7.20
94.33
3.1
1.9
—
—
—
0
0
232
595
6.77
93.98
3.5
1.9
—
—
—
0
0
156
268
8.25
93.82
3.2
1.6
—
—
—
0
0
96
105
11.26
82.53
2.9
3.0
—
—
—
0
0
98
114
10.62
80.50
2.7
1.7
—
—
—
0
0
99
121
10.12
78.27
2.9
1.8
—
—
—
0
0
87
99
10.58
72.34
2.4
1.5
—
—
—
0
0
75
69
12.76
72.15
1.5
1.3
—
—
—
0
0
75
69
12.76
72.15
1.5
1.3
—
—
—
0
0
428
2246
12.11
71.21
27.2
6.5
2.03
2.02
e9/l
0.01
422
1957
78
78
11.81
71.00
2.3
1.5
—
—
—
0
0
427
2269
11.54
69.00
28.9
7.0
0.17
0.19
e9/l
2.43
422
1961
76
78
11.45
67.87
2.7
1.9
—
—
—
0
0
57
39
16.51
64.99
4.9
4.1
—
—
—
0
0
65
57
13.09
64.26
2.4
1.6
—
—
—
0
0
71
75
10.99
61.99
2.0
1.4
—
—
—
0
0
428
2435
10.29
59.45
38.2
10.1
3.88
3.99
e9/l
0.52
423
2095
52
36
16.13
58.80
2.0
1.8
—
—
—
0
0
61
59
11.75
56.44
2.3
1.6
—
—
—
0
0
194
623
4.62
55.68
4.3
2.3
2.37
2.37
g/l
0.01
194
573
369
1948
5.30
52.86
36.9
10.9
0.00
0.00
e9/l
0.20
339
1550
76
111
7.99
51.19
1.7
1.2
—
—
—
0
0
96
182
6.38
50.56
2.9
1.6
—
—
—
0
0
78
122
7.48
49.38
5.2
2.7
0.27
0.73
g/l
0.84
70
112
74
110
7.81
49.01
5.2
2.4
0.01
0.04
g/l
0.36
69
105
82
137
7.05
48.81
5.3
2.4
3.01
2.96
g/l
0.16
77
129
344
1788
4.53
48.54
24.1
6.9
1.21
1.22
mmol/l
2.10
338
1654
84
145
6.85
48.46
5.2
2.3
3.97
4.35
g/l
2.08
79
137
84
145
6.85
48.46
5.2
2.3
2.91
3.82
g/l
3.46
79
137
84
145
6.85
48.46
5.2
2.3
7.17
7.29
g/l
0.22
79
137
248
1033
3.99
48.23
3.4
2.2
2.77
2.84
mg/l
0.17
236
889
68
96
8.12
47.04
1.8
1.6
—
—
—
0
0
258
1130
3.87
46.02
6.9
3.2
0.17
0.44
e6/l
2.73
210
815
73
116
7.28
45.42
2.9
3.3
4.25
1.87
index
0.86
32
66
149
450
4.40
45.18
3.4
2.0
311.85
372.59
nmol/l
2.88
139
428
75
129
6.74
43.24
5.6
2.3
6.71
10.17
g/l
10.38
69
120
63
93
7.68
41.79
7.1
3.9
3.36
2.74
ratio
0.20
34
51
79
148
6.22
41.79
2.8
2.5
1.38
1.43
g/l
0.12
68
133
66
103
7.30
41.65
7.2
4.0
18.54
28.17
mg/l
1.83
50
88
66
103
7.30
41.65
7.2
4.0
33.99
105.89
mg/l
0.66
49
89
43
39
12.04
41.23
1.6
1.2
0.41
0.38
u/ml
0.03
32
19
350
1981
4.08
40.36
23.6
7.5
1.21
1.21
mmol/l
0.47
319
1722
67
110
6.95
40.30
5.5
2.4
0.01
0.00
g/l
0.49
62
100
48
53
9.98
40.19
4.1
2.0
—
—
—
0
0
45
46
10.72
39.80
4.3
2.1
—
—
—
0
0
39
32
13.21
39.76
1.9
1.2
—
—
—
0
0
341
1908
3.93
39.75
5.5
2.6
82.79
76.26
nmol/l
3.88
334
1732
269
1303
3.52
39.25
7.3
3.3
20.08
53.86
e6/l
1.76
220
984
50
61
9.06
38.80
2.9
1.6
—
—
—
0
0
210
890
3.47
37.68
6.0
2.7
4.36
5.89
e6/l
1.31
199
807
56
82
7.63
37.31
2.8
1.5
—
—
—
0
0
168
624
3.65
36.99
2.9
2.6
158.85
120.06
ug/g
0.56
142
499
76
159
5.52
35.54
3.0
1.2
40.64
37.57
u/l
0.56
71
143
39
40
10.55
34.32
3.3
1.1
—
—
—
0
0
38
39
10.52
33.41
3.4
1.1
—
—
—
0
0
111
340
3.97
32.03
25.2
8.8
1.21
1.29
mmol/l
0.46
106
334
53
88
6.67
31.35
2.4
1.8
—
—
—
0
0
434
3105
6.79
31.13
27.4
8.1
84.34
80.67
u/l
1.02
429
2932
82
211
4.50
29.79
2.4
1.7
—
—
—
0
0
30
26
12.26
29.42
1.1
5.3
—
46.60
u/ml
—
0
5
131
480
3.41
28.58
4.3
3.5
5.92
6.59
umol/l
0.25
120
420
60
123
5.45
28.51
2.9
1.3
—
—
—
0
0
40
54
8.01
28.43
1.7
1.3
—
—
—
0
0
334
2082
3.13
27.82
5.9
3.0
192.89
99.45
ug/l
2.40
326
1947
199
946
2.93
27.48
4.0
1.9
1.57
1.16
mg/l
0.46
165
744
30
29
10.99
27.39
1.5
1.3
—
—
—
0
0
154
639
3.11
27.12
5.1
3.1
2.67
2.54
e6/l
0.05
72
298
46
79
6.35
26.24
2.0
1.5
—
—
—
0
0
357
2353
3.21
26.08
16.8
5.2
6.62
6.57
mmol/l
0.16
349
2215
210
1057
2.80
25.63
5.0
3.0
1300.78
931.59
ng/l
0.66
195
876
158
685
2.98
25.52
4.9
2.9
1.39
0.83
e6/l
1.02
77
344
218
1127
2.76
25.14
2.1
1.6
22.15
21.17
nmol/l
0.40
211
947
48
90
5.83
25.03
2.0
1.5
96.60
156.25
au/ml
2.36
22
34
29
31
9.91
24.65
2.8
1.6
—
—
—
0
0
67
174
4.33
23.86
1.8
1.4
—
—
—
0
0
41
71
6.24
23.15
1.6
1.1
—
—
—
0
0
374
2622
3.16
22.69
9.4
4.5
15.00
1002.77
e6/l
—
5
44
29
36
8.52
21.99
1.4
1.2
—
—
—
0
0
279
1706
2.58
21.86
3.0
2.0
96.71
98.32
pmol/l
0.24
172
862
106
398
3.15
21.69
18.6
10.4
0.72
0.98
mmol/l
0.23
89
333
105
393
3.16
21.59
2.7
2.6
33.42
33.46
u/l
0.00
83
326
30
40
7.95
21.46
2.6
1.7
—
—
—
0
0
30
40
7.95
21.46
2.6
1.7
—
—
—
0
0
30
40
7.95
21.46
2.6
1.7
—
—
—
0
0
43
85
5.47
21.14
3.3
1.9
123.94
130.11
g/l
0.39
17
65
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
45
93
5.25
21.06
6.4
3.9
0.37
0.36
iu/ml
0.03
28
49
242
1405
2.50
20.88
6.3
3.3
2.34
2.36
mmol/l
2.53
228
1281
84
281
3.43
20.70
25.7
4.5
24.41
24.16
mmol/l
0.29
84
281
193
1012
2.55
20.70
7.8
2.8
322.72
328.20
umol/l
0.29
180
901
71
216
3.70
20.20
1.8
2.1
6.24
4.90
iu/ml
0.29
13
43
120
515
2.79
19.08
23.3
7.8
104.17
104.17
mmol/l
0.00
120
515
103
414
2.91
18.47
22.4
4.5
1.68
1.75
mmol/l
0.08
95
350
86
313
3.14
18.36
7.1
4.2
84.36
72.82
ng/l
0.64
81
279
267
1685
2.37
18.29
13.9
10.3
1.13
1.16
inr
0.44
213
1382
46
110
4.53
18.09
2.0
1.4
212.17
228.94
u/ml
0.09
30
55
31
52
6.32
18.00
4.1
1.4
—
—
—
0
0
31
52
6.32
18.00
4.1
1.4
—
—
—
0
0
31
52
6.32
18.00
4.1
1.4
—
—
—
0
0
30
50
6.34
17.53
4.2
1.4
—
—
—
0
0
89
341
2.99
17.32
2.2
1.5
—
—
—
0
0
146
722
2.49
17.20
5.3
3.5
68.83
265.55
ng/l
2.49
105
512
33
62
5.65
17.09
1.4
1.4
—
—
—
0
0
51
138
4.03
17.06
1.6
1.4
370.89
320.44
ug/g
0.77
27
80
29
49
6.24
16.71
4.3
1.4
—
—
—
0
0
29
49
6.24
16.71
4.3
1.4
—
—
—
0
0
52
150
3.78
15.89
1.5
1.3
—
—
—
0
0
92
376
2.80
15.83
4.7
3.1
—
—
—
0
0
313
2197
2.29
15.60
7.1
3.7
0.00
0.00
estimate
-0.00
85
462
27
22
12.95
15.55
3.0
1.6
—
—
—
0
0
204
1209
2.22
15.47
3.6
2.1
112.98
177.54
u/l
1.88
199
1148
27
23
12.39
15.25
3.0
1.6
—
—
—
0
0
30
58
5.46
15.05
2.6
2.5
5.35
24.47
iu/ml
—
6
7
27
24
11.87
14.96
3.0
1.6
—
—
—
0
0
314
2236
2.24
14.68
7.0
3.8
0.00
0.70
estimate
0.51
83
439
174
984
2.23
14.65
5.1
2.3
—
—
—
0
0
312
2219
2.23
14.59
7.1
3.7
15.42
6.49
estimate
0.24
86
467
119
577
2.43
14.32
1.9
1.7
1270.31
1208.11
nmol/l
0.26
104
434
24
19
13.25
14.05
1.7
1.5
—
—
—
0
0
141
752
2.25
13.52
3.5
2.5
2.45
2.45
mmol/l
0.34
129
679
60
212
3.10
13.32
4.6
2.9
232.21
159.92
ng/l
0.37
52
196
21
14
15.64
13.21
1.9
2.2
—
—
—
0
0
18
8
23.33
12.98
1.6
1.9
—
—
—
0
0
43
129
3.57
12.37
1.6
1.4
1.55
0.00
iu/ml
0.48
13
17
43
129
3.57
12.37
4.1
1.8
190.08
268.90
ug/l
0.53
38
121
42
127
3.54
11.94
1.5
1.2
3.36
0.90
u/ml
—
5
6
23
43
5.57
11.94
1.2
1.2
—
—
—
0
0
36
99
3.86
11.74
3.7
1.4
10.88
12.37
e6/l
0.06
26
75
51
177
3.11
11.64
1.7
1.2
0.48
1.13
u/ml
—
6
10
24
48
5.22
11.59
1.2
1.2
—
—
—
0
0
47
156
3.24
11.55
1.4
1.3
—
—
—
0
0
19
14
14.09
11.55
1.8
1.6
—
—
—
0
0
22
41
5.58
11.45
1.5
1.4
—
—
—
0
0
36
101
3.78
11.41
3.7
1.5
54.18
258.14
e6/l
1.38
28
79
197
1257
1.98
11.38
3.9
2.6
61.69
63.87
u/l
0.13
192
1169
23
45
5.32
11.37
1.2
1.2
—
—
—
0
0
23
45
5.32
11.37
1.2
1.2
—
—
—
0
0
43
137
3.36
11.28
1.3
1.1
—
—
—
0
0
22
43
5.32
10.89
1.2
1.2
—
—
—
0
0
25
55
4.75
10.84
1.2
1.2
—
—
—
0
0
40
128
3.32
10.42
1.6
1.2
7.60
55.85
u/ml
—
8
14
42
139
3.22
10.37
1.3
1.1
—
—
—
0
0
27
67
4.22
10.10
2.0
1.5
20.98
27.63
ng/l
0.56
27
67
45
158
3.05
10.06
1.5
1.2
2.74
2.95
u/ml
—
5
15
45
159
3.03
9.95
1.5
1.3
1.56
6.24
u/ml
—
7
25
21
26
8.40
9.93
3.1
4.2
0.48
0.92
index
1.77
21
26
22
48
4.76
9.63
3.0
3.7
51.33
41.22
u/ml
—
6
14
71
324
2.41
9.53
2.9
2.4
5.03
14.54
au/ml
—
6
23
53
211
2.71
9.43
24.0
3.1
0.57
0.60
%
0.33
53
211
256
1875
1.81
8.95
5.9
2.7
—
—
estimate
—
0
0
357
2910
1.97
8.74
5.2
3.3
—
—
—
0
0
21
48
4.53
8.70
4.5
2.2
32.14
32.77
pg
0.26
21
48
15
13
11.88
8.62
4.9
5.0
—
—
—
0
0
18
23
8.09
8.44
3.1
1.9
—
—
—
0
0
18
23
8.09
8.44
3.1
1.9
—
—
—
0
0
18
23
8.09
8.44
2.6
2.0
—
—
—
0
0
18
23
8.09
8.44
3.1
1.9
—
—
—
0
0
18
23
8.09
8.44
3.1
1.9
—
—
—
0
0
18
23
8.09
8.44
2.6
2.0
—
—
—
0
0
19
41
4.79
8.42
2.6
1.8
90.23
89.82
%
0.12
19
41
154
982
1.85
8.38
2.0
1.7
—
—
—
0
0
21
50
4.35
8.28
1.9
1.3
—
—
—
0
0
23
59
4.05
8.25
3.5
1.8
1.68
1.59
mmol/l
0.16
23
59
16
18
9.16
8.10
1.7
1.1
—
—
—
0
0
55
242
2.44
7.97
23.4
3.6
123.69
130.58
g/l
1.36
55
236
17
22
7.98
7.94
1.5
1.9
11.24
11.11
umol/l
0.03
17
22
13
10
13.33
7.92
1.3
1.3
—
—
—
0
0
16
19
8.68
7.87
3.3
1.9
—
—
—
0
0
16
19
8.68
7.87
3.3
1.9
—
—
—
0
0
16
19
8.68
7.87
3.3
1.9
—
—
—
0
0
450
4085
3.96
7.83
62.1
14.1
19.57
21.64
mg/l
0.98
433
3265
410
3563
2.25
7.72
67.8
17.7
14.10
13.48
%
14.31
410
3528
205
1451
1.74
7.68
5.3
3.4
25.65
72.39
ng/l
0.55
145
934
60
281
2.30
7.56
15.3
4.1
1.38
1.62
mmol/l
0.18
49
204
17
24
7.31
7.54
1.4
1.1
—
—
—
0
0
19
45
4.36
7.54
1.2
1.1
—
—
—
0
0
19
32
6.14
7.45
1.1
1.6
—
—
—
0
0
16
21
7.85
7.44
1.7
1.1
—
—
—
0
0
16
22
7.49
7.24
1.2
1.0
986.50
1669.05
miu/ml
1.67
16
22
18
43
4.31
7.07
1.2
1.1
—
—
—
0
0
24
72
3.46
6.92
1.2
1.2
1.71
3.22
u/ml
—
7
32
40
162
2.61
6.88
2.5
1.7
10.92
9.04
u/l
0.26
31
120
10
6
17.00
6.77
1.6
1.0
—
—
—
0
0
171
1187
1.70
6.65
1.4
1.5
0.45
1.78
u/ml
3.24
25
342
19
50
3.92
6.60
1.9
1.3
—
—
—
0
0
14
19
7.56
6.45
1.8
1.3
—
—
—
0
0
14
19
7.56
6.45
3.7
1.7
536.50
1060.84
mg
0.75
14
19
13
16
8.32
6.37
1.4
1.0
—
—
—
0
0
62
316
2.11
6.34
3.0
2.4
64.79
72.69
ml/min/173m2
0.66
33
135
11
10
11.23
6.32
1.3
1.5
—
—
—
0
0
25
82
3.16
6.29
1.1
1.1
—
1.86
—
0
15
14
20
7.18
6.26
1.1
1.0
—
—
—
0
0
23
72
3.31
6.23
1.2
1.2
1.25
1.48
u/ml
—
8
27
17
32
5.47
6.21
2.8
5.9
102.59
95.75
%
0.23
17
32
17
32
5.47
6.21
1.3
1.1
104.24
109.06
pmol/l
0.11
17
32
16
28
5.88
6.20
2.8
2.6
73.31
105.39
ug/l
0.46
16
28
16
39
4.21
6.13
1.1
1.1
—
—
—
0
0
57
286
2.13
6.07
2.4
1.5
25.45
24.49
iu/l
0.08
50
234
9
6
15.25
5.92
5.6
4.8
—
—
—
0
0
50
243
2.18
5.77
1.4
1.3
—
—
—
0
0
14
23
6.24
5.73
1.2
1.2
—
—
—
0
0
132
887
1.68
5.65
1.4
1.3
22.01
33.41
iu/ml
0.92
36
264
31
123
2.63
5.58
5.4
1.7
—
—
—
0
0
424
3845
2.14
5.40
45.5
13.5
86.49
85.50
ml/min/173m2
0.40
415
3502
38
171
2.33
5.26
1.3
1.3
215.93
254.62
miu/ml
0.27
15
83
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
22
6.05
5.25
1.4
1.1
—
—
—
0
0
20
64
3.22
5.25
3.0
1.9
5.56
4.76
mmol/24h
0.55
20
55
5
0
+∞
5.22
1.2
0.0
—
—
—
0
0
25
92
2.81
5.19
2.0
1.5
8418.78
15168.31
e6/l
0.47
18
64
14
27
5.31
5.12
1.6
1.9
—
—
—
0
0
8
6
13.53
5.09
1.5
1.3
—
—
—
0
0
8
6
13.53
5.09
1.0
1.2
—
—
—
0
0
8
6
13.53
5.09
1.6
1.5
—
—
—
0
0
11
16
7.01
4.98
1.3
1.3
—
—
—
0
0
11
17
6.60
4.80
1.3
1.1
116.73
193.98
mmol/24h
2.37
11
17
19
63
3.10
4.72
1.1
1.3
0.51
0.53
nmol/l
0.10
19
57
25
97
2.67
4.72
1.4
1.3
—
—
—
0
0
18
58
3.19
4.68
2.8
1.3
13.85
3.23
ug/l
0.73
18
49
10
14
7.27
4.67
2.0
1.2
13.10
12.64
u/l
—
10
14
118
812
1.61
4.49
1.4
1.3
6.98
10.06
u/ml
0.26
26
315
12
24
5.10
4.34
2.1
1.3
470.75
705.55
u/l
0.22
12
24
163
1216
1.52
4.33
8.3
3.8
0.00
0.00
estimate
0.50
80
440
15
39
3.94
4.23
1.1
1.1
—
—
—
0
0
12
25
4.90
4.21
1.1
1.0
—
—
—
0
0
14
35
4.09
4.13
5.2
1.9
21.67
38.50
mg/l
—
9
24
9
14
6.53
4.00
1.1
1.1
—
—
—
0
0
9
14
6.53
4.00
1.1
1.1
—
—
—
0
0
113
794
1.56
3.88
2.1
1.7
505.85
17620928.74
pmol/l
0.50
108
664
12
28
4.37
3.84
1.2
1.0
—
—
—
0
0
9
15
6.09
3.83
1.1
1.1
—
—
—
0
0
14
44
3.25
3.80
4.5
3.0
13.08
14.76
mu/l
0.27
14
44
8
12
6.76
3.68
1.0
1.3
—
—
—
0
0
9
16
5.71
3.67
1.7
1.0
—
—
—
0
0
28
132
2.19
3.53
4.5
1.9
—
—
—
0
0
13
37
3.58
3.43
4.3
2.3
—
—
—
0
0
8
14
5.79
3.35
2.4
3.4
0.63
0.61
mmol/l
—
8
14
178
1410
1.42
3.30
5.2
3.5
6.86
7.82
mmol/l
2.07
167
1200
6
7
8.66
3.27
1.5
1.3
—
—
—
0
0
9
19
4.81
3.25
1.7
1.4
—
—
—
0
0
9
19
4.81
3.25
1.7
1.4
—
—
—
0
0
18
72
2.56
3.25
1.1
1.2
—
—
—
0
0
7
11
6.44
3.19
1.7
1.0
—
—
—
0
0
7
11
6.44
3.19
1.0
1.3
—
—
—
0
0
23
106
2.23
3.08
1.4
1.3
—
—
—
0
0
6
8
7.58
3.06
1.2
1.3
—
—
—
0
0
8
16
5.07
3.06
1.8
1.3
—
—
—
0
0
8
16
5.07
3.06
1.8
1.3
—
—
—
0
0
10
26
3.91
2.99
3.5
1.5
3.66
5.62
umol/l
—
10
21
12
37
3.30
2.95
1.2
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
9
22
4.15
2.89
2.7
1.6
168.89
119.36
%
—
9
22
36
202
1.85
2.86
21.5
4.4
24.15
24.51
mmol/l
0.36
36
194
18
78
2.36
2.78
2.2
1.1
69.00
103.32
iu/ml
—
7
19
6
10
6.06
2.70
1.0
1.0
132.00
104.60
%
—
6
10
6
10
6.06
2.70
2.3
2.4
—
—
—
0
0
8
19
4.26
2.69
1.1
1.2
97.50
83.22
u/l
—
8
19
5
165
0.30
2.60
1.4
1.4
—
—
—
0
0
5
7
7.21
2.55
1.2
1.0
—
—
—
0
0
5
7
7.21
2.55
1.2
1.0
—
—
—
0
0
31
173
1.85
2.53
1.9
1.6
278.23
294.37
mu/l
0.20
31
160
13
51
2.59
2.46
1.0
1.2
—
72.20
—
0
5
155
1250
1.36
2.45
6.9
3.2
0.00
0.07
estimate
0.52
75
374
322
2896
1.36
2.44
5.8
3.5
59.93
42.82
u/l
2.45
315
2748
29
161
1.85
2.41
5.2
3.9
24.78
25.04
mmol/l
0.18
29
156
15
64
2.39
2.41
2.5
3.6
27.53
22.17
nmol/l
0.54
15
59
5
8
6.30
2.37
2.0
2.1
—
—
—
0
0
449
4320
2.08
2.37
62.1
17.7
78.00
72.16
umol/l
1.90
449
4274
55
370
1.55
2.28
3.9
4.3
28.73
19.63
ug/l
0.13
48
303
197
1666
1.32
2.21
7.4
3.5
0.00
0.02
estimate
0.96
78
383
82
606
1.43
2.16
2.8
2.3
—
—
—
0
0
7
19
3.72
2.16
1.1
1.2
43.14
27.14
u/l
—
7
19
408
3845
1.49
2.15
7.1
5.5
1.83
1.86
mu/l
0.17
401
3595
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
7
20
3.54
2.06
1.1
1.0
103.86
116.55
%
—
7
20
360
3333
1.35
2.00
6.0
4.5
14.91
14.65
pmol/l
1.28
350
3080
26
427
0.59
1.92
9.8
5.9
—
—
—
0
0
7
22
3.21
1.88
6.1
3.8
1.79
1.05
%
—
7
22
6
17
3.56
1.84
1.7
3.2
198.83
203.59
u/l
—
6
17
5
13
3.87
1.72
3.6
2.0
139.20
148.46
%
—
5
13
32
204
1.61
1.70
1.7
1.5
0.22
0.31
mg/l
0.68
13
93
150
1260
1.28
1.69
6.5
4.1
17.29
8.08
mg/mmol
1.14
99
765
15
76
2.01
1.66
2.1
1.8
—
—
—
0
0
42
292
1.48
1.55
2.9
2.1
—
—
—
0
0
5
15
3.36
1.52
1.2
1.1
—
—
—
0
0
73
567
1.34
1.45
2.7
2.1
—
—
—
0
0
49
357
1.42
1.43
2.8
2.2
—
—
—
0
0
21
128
1.67
1.35
2.1
2.1
3.21
3.60
iu/l
—
5
51
7
32
2.21
1.08
1.1
1.6
—
—
—
0
0
46
351
1.34
1.06
2.0
1.3
99.22
154.17
u/ml
0.73
19
149
200
1812
1.18
1.01
2.2
2.0
1.42
1.37
mmol/l
0.48
181
1549
0
29
0.00
0.98
0.0
1.3
—
10.24
—
0
29
37
485
0.74
0.96
5.1
4.6
30.33
32.09
%
0.42
30
324
9
52
1.74
0.93
1.1
1.4
218.33
317.15
mu/l
—
9
41
35
262
1.36
0.93
2.3
2.2
6.02
5.78
ug/l
0.04
30
232
23
163
1.43
0.83
2.2
1.5
—
—
—
0
0
10
165
0.60
0.83
1.3
1.9
—
—
—
0
0
62
515
1.24
0.78
2.5
3.0
0.54
0.73
ug/l
2.96
44
298
25
185
1.37
0.73
1.7
2.3
217.86
5325.84
u/l
—
7
73
6
106
0.56
0.73
1.8
1.7
—
—
—
0
0
40
496
0.79
0.72
2.0
1.9
3.36
3.48
ratio
0.20
28
396
88
775
1.17
0.62
1.8
1.5
—
—
—
0
0
6
41
1.47
0.50
1.0
1.1
—
—
—
0
0
31
254
1.24
0.48
1.0
1.0
—
—
—
0
0
386
3771
1.14
0.46
7.2
6.0
38.88
38.62
mmol/mol
0.21
371
3570
394
4017
0.88
0.44
5.6
5.0
4.64
4.73
mmol/l
0.95
381
3777
8
59
1.36
0.41
1.0
1.0
—
—
—
0
0
452
4479
1.30
0.38
77.9
21.8
247.53
256.14
e9/l
1.56
452
4398
452
4479
1.30
0.38
77.5
21.8
90.67
90.48
fl
0.32
452
4444
372
3796
0.90
0.37
5.0
4.2
1.37
1.27
mmol/l
2.00
358
3531
105
971
1.11
0.37
6.5
3.7
1.02
1.02
kg/l
0.20
66
642
452
4481
1.29
0.36
77.7
21.8
4.38
4.53
e12/l
6.85
452
4389
452
4481
1.29
0.36
82.5
22.3
39.20
40.65
%
9.50
452
4444
5
79
0.63
0.35
1.4
1.5
30.47
54.10
ug/l
—
5
79
452
4483
1.27
0.33
78.4
21.9
129.50
135.90
g/l
14.50
452
4447
32
364
0.87
0.28
1.7
1.8
3.32
3.49
mmol/l
0.37
22
267
395
4000
0.92
0.24
5.5
4.9
1.47
1.49
mmol/l
0.40
377
3744
13
107
1.22
0.22
1.2
1.5
—
—
—
0
0
5
43
1.16
0.21
2.8
2.7
106.00
105.16
mmol/l
—
5
43
7
88
0.79
0.14
2.6
1.6
—
—
—
0
0
72
688
1.06
0.13
3.3
4.3
17.03
21.41
%
2.86
33
297
14
156
0.89
0.10
1.4
1.1
0.41
0.65
ratio
—
5
18
16
146
1.10
0.08
2.3
1.8
46.94
38.84
nmol/l
0.41
16
140
8
77
1.04
0.07
2.1
5.8
325.63
368.93
umol/l
—
8
70
59
572
1.04
0.06
1.6
1.9
1.64
1.42
%
1.13
50
513
389
3871
1.03
0.06
5.6
4.8
5.91
5.85
mmol/l
0.37
378
3595
404
4052
0.98
0.03
6.2
5.6
2.66
2.80
mmol/l
2.27
389
3799
18
172
1.05
0.02
1.6
1.2
0.82
0.92
g/l
0.87
18
172
14
135
1.04
0.00
1.6
1.4
—
—
—
0
0
16
164
0.97
0.00
1.6
1.1
1.69
1.54
g/l
1.55
16
164
6
67
0.89
0.00
1.8
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.5
—
59.13
—
0
6
8
81
0.99
-0.00
1.3
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
5.84
—
0
5
0
7
0.00
-0.00
0.0
1.3
—
1.19
—
0
7
21
210
1.00
-0.00
1.5
1.6
944.90
949.20
mu/l
0.01
15
179
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_IMMUDEFANTIBODYNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_IMMUDEFANTIBODYNAS | 3.692 [2.74, 4.98] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.678 |
During the follow-up period (1.1.1998 — 31.12.2019), 114 out of 759 females with D3_IMMUDEFANTIBODYNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_IMMUDEFANTIBODYNAS | 4.194 [2.91, 6.04] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 101 out of 537 males with D3_IMMUDEFANTIBODYNAS died.
Mortality risk
Mortality risk for people of age
years, who have D3_IMMUDEFANTIBODYNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.49% | 0.783% |
| 5 | 2.474% | 4.738% |
| 10 | 6.1% | 11.305% |
| 15 | 11.228% | 20.533% |
| 20 | 18.82% | 33.16% |
Relationships between endpoints
↥Index endpoint: D3_IMMUDEFANTIBODYNAS – Other and unspecified immunodeficiencies with predominantly antibody defects
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data